EZH2 and plasma cell myeloma: It was also found that expression of EZH2 exhibited a strong positive correlation with dysfunctional T-cell phenotypes of KIRC, LUAD, BRCA-LumA, HNSC, myeloma, and colorectal cancer (Figure 9D).